Product Information
GLIMEPIRIDE 2 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0375 per EA under NDC 43547039510. Its NADAC has been published 488 times since May 31, 2017.
FDA first approved this application on Dec 23, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547039510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077370FDA Approved
12/23/2005
TE Code
AB
On Market Since
1/30/2017
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 2 MG TABLET has been published 488 times since May 31, 2017, and over the history we have for it it has declined 49.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0375 per EA |
|---|---|
| All-time high | $0.0921 (Aug 16, 2017) |
| All-time low | $0.0284 (Apr 17, 2024) |
| 52-week high | $0.0375 |
| 52-week low | $0.0295 |
| Median price | $0.0430 |
| Average price | $0.0509 |
| Largest weekly change | -26.3% (Apr 17, 2024) |
| Weeks tracked | 488 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glimepiride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 2 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0375 per EA (NDC 43547039510), effective Sep 30, 2026.
How has the price of GLIMEPIRIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 2 MG TABLET has declined 49.8%. It has been tracked across 488 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 2 MG TABLET?
Since May 31, 2017, the NADAC for GLIMEPIRIDE 2 MG TABLET has ranged from a low of $0.0284 (Apr 17, 2024) to a high of $0.0921 (Aug 16, 2017), with a median of $0.0430 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 2 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLIMEPIRIDE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLIMEPIRIDE 2 MG TABLET?
GLIMEPIRIDE 2 MG TABLET (NDC 43547039510) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.